Overview of This Study:

Research for this study involved estimating the current size and forecast of the cell isolation market through secondary and primary research. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent markets. The next step was to validate these findings & assumptions with industry experts across the value chain through primary research.

The market estimates arrived by top-down and other approaches were triangulated to estimate the market size of segments and subsegments. Market growth forecasts were derived by developing assumptions based on revenue growth & key developments from major market players, industry drivers and inputs from demand and supply side experts.

Projected Surge in Global Revenue:

The size of global cell isolation market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $8.2 billion by 2028, growing at a CAGR of 13.4% from 2023 to 2028. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

OPPORTUNITY: Growth opportunities in emerging markets

Emerging markets such as China, India, and Brazil are experiencing rapid growth in their biopharmaceutical industries. This is driven by factors such as increasing healthcare spending, a growing aging population, and a rise in chronic diseases. The increasing demand for biopharmaceuticals in these markets is driving the need for cell isolation technologies to develop and manufacture these products. Moreover, emerging markets are investing in the development and adoption of advanced technologies such as microfluidics, magnetic cell separation, and flow cytometry. This is improving the efficiency and accuracy of cell isolation processes, and making these technologies more accessible and affordable in these markets.

CHALLENGE: Difficulties to develop cell therapies

The development of cell therapies is a major challenge for the market, as it requires the isolation and manipulation of specific cell types that can be used for therapeutic purposes. Different cell types have different characteristics and functions, which makes it difficult to isolate and purify specific cell populations. This can result in a heterogeneous population of cells, which can reduce the effectiveness of the therapy. Isolated cells need to be viable and functional in order to be used in therapies. However, the isolation process can damage cells, which can reduce their viability and functionality. The quality of isolated cells needs to be carefully controlled in order to ensure their safety and effectiveness. This can be challenging, as cells can be affected by a range of environmental factors, such as temperature, pH, and oxygen levels. Overall, these obstacles to the development of cell therapies are significant challenges for the market.

Asia Pacific is likely to grow at double digit growth rate during the forecast period.

The Asia Pacific region is estimated to grow at the highest CAGR in the cell isolation market during the forecast period, this is mainly due to the rising geriatric population and increasing number of hospitals in Asian countries. Moreover, increasing chronic diseases in the countries of this region is likely to boost the market. Also, growing infectious diseases in the region is attracting several foreign investors in the market. Governments in the APAC region are supporting research in various ways, such as funding research institutes and offering tax incentives to biotech and life sciences companies. This has led to an increased demand for cell isolation technologies to support this research.

Key Players:

Some of the prominent players in the cell isolation market are Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), F. Hoffmann-La Roche Ltd. (Switzerland), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Alfa Laval (Sweden), Sartorius AG (Germany), Akadeum Life Sciences (US), Bio-Techne (US), PerkinElmer Inc. (US), Invent Biotechnologies, Inc. (US), Takara Bio, Inc. (Japan), MiCareo Inc. (US), Proteintech Group, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Promega Corporation (US), PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany), and MagBio Genomics (US).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]